Interestingly, as the recovered mice age, they develop a secondary lethal progressive demyelinating disease starting around 40 weeks after tamoxifen injection that is mediated by MOG35–55-specific CD4+ T cell infiltration into the CNS during the late stages of disease (Traka et al., 2016). Here, CD4 is linked to demyelinating disease.